Transforming legacy nuclear waste into hope for cancer patients is a story of innovation and impact. Our Isotek team’s work on the U-233 project at Oak Ridge National Laboratory has been nominated for the WNE Innovation Award, recognizing efforts to innovate beyond electricity. Through a unique partnership with the US Department of Energy and TerraPower, the project is addressing two critical needs: cleaning up Cold War-era radioactive waste and enabling the production of actinium 225, a promising isotope for targeted cancer therapies. By safely extracting thorium 229 from uranium 233, Isotek has helped increase annual cancer treatment doses from just 4,000 to 100,000 worldwide. This achievement reflects the dedication of our people and the power of collaboration. More than 70 percent of the U-233 inventory has been safely dispositioned, saving millions of taxpayer dollars and expanding access to life-changing treatments. Read more about the project in the comments.
Incredible innovation turning nuclear legacy into lifesaving potential. Congratulations to the AtkinsRéalis and Isotek teams on this meaningful achievement 👏
Read more here: https://www.atkinsrealis.com/en/projects/isotek-u-233